From The Analytical Scientist:
Inspired by the individuals on The Power List?
The University of Tasmania’s Emily Hilder features in this year’s Power List – she also appeared on the 2013 Power List of the Top 100 most influential analytical scientists. Here, Emily shares information on an ambitious new collaborative project – and outlines who she’s looking to work with.
Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.
This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.